期刊文献+

中医药在支气管哮喘方面的研究进展 被引量:6

Research progress of traditional Chinese medicine in bronchial asthma
原文传递
导出
摘要 支气管哮喘是临床常见的慢性呼吸系统疾病之一,西医治疗以糖皮质激素和支气管扩张药物为主,但不良反应较多,导致患者依从性差、复发率高。中医药防治支气管哮喘具有一定优势,可使患者减轻激素依赖性,减少不良反应的发生,减少复发次数。该文对中医药防治支气管哮喘的病因治则、辨证论治及临床研究进展作一综述,以期为支气管哮喘的防治提供新思路。 Bronchial asthma is one of the common chronic respiratory diseases in clinic.Western medicine mainly treats with glucocorticoids and bronchodilation drugs,but there are many adverse reactions,resulting in poor patient compliance and high recurrence rate.Traditional Chinese medicine(TCM)has certain advantages in the prevention and treatment of bronchial asthma,which can reduce the hormone dependence of patients,reduce the occurrence of adverse reactions,and reduce the number of recurrence.This article reviews the etiology and treatment,syndrome differentiation and clinical research progress of TCM in the prevention and treatment of bronchial asthma,in order to provide new ideas for the prevention and treatment of bronchial asthma.
作者 李曼曼 朱林筠 吴彤 周海凤 LI Manman;ZHU Linyun;WU Tong;ZHOU Haifeng(National Key Laboratory of Lead Druggability Research,Shanghai Institute of Pharmaceutical Industry Co.Ltd.,China State Institute of Pharmaceutical Industry,Shanghai 201203;Department of Respiratory and Critical Care Medicine,Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200062,China)
出处 《世界临床药物》 CAS 2023年第10期1119-1121,共3页 World Clinical Drug
基金 上海市2020年度“科技创新行动计划”生物医药科技支撑专项项目(20S21900700)。
关键词 支气管哮喘 缓解期 中医药 辨证 研究进展 bronchial asthma remission period traditional Chinese medicine syndrome differentiation research progress
  • 相关文献

参考文献18

二级参考文献168

共引文献837

同被引文献156

引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部